Judge approves Bayer's $7.25 billion Roundup settlement
Life Sciences
Friday, November 20, 2026
- Updated Nov 20, 2026 19:04
A Missouri state court judge on Friday gave final approval to Bayer's $7.25 billion settlement of lawsuits alleging its Roundup weedkiller causes cancer, a deal announced in February that aims to resolve nearly all current and future US claims.
Why it matters: The approval removes the largest single litigation overhang on Bayer, whose shares have fallen sharply since it bought Monsanto for $63 billion in 2018, though about 200 federal cases remain outside the deal.
Data as of Reuters report carried by The Guardian, read in full on November 20, 2026, corroborated by Bloomberg and Investing.com headlines on the same approval. Developing item.
Judge Timothy Boyer of a state court in St Louis, Missouri, on Friday approved Bayer’s $7.25 billion settlement of Roundup cancer lawsuits, finding it fair, reasonable and adequate, and overruling objections that individual payouts would be too low compared with earlier settlements. The deal, announced in February, aims to resolve nearly all current and future Roundup claims in the United States, where Bayer had faced about 65,000 claims in state and federal courts.
The settlement excludes some lawsuits still pending in federal court, about 200 of which Bayer says remain in litigation. Bayer chief executive Bill Anderson called the final approval a decisive milestone in the company’s strategy to mitigate the risks of pending and future Roundup litigation.
Sources
- Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer - The Guardian (Reuters) - 2026-11-20
- Missouri judge approves Bayer's $7.25 billion Roundup settlement - Investing.com - 2026-11-20